Enhancing Market Access for Product X in NT1

The presentation provides an overview of Narcolepsy Type 1 (NT1), highlighting its impact, diagnostic challenges, and associated burdens. It introduces Product X with its unique mechanism, efficacy, and affordability compared to current therapies. Lastly, it outlines value propositions such as improved patient outcomes, simplified access, and broad market potential, emphasizing strategic implications for healthcare stakeholders.